Celcuity (CELC) Operating Expenses (2016 - 2026)
Celcuity's (CELC) quarterly Operating Expenses came in at $49.2 million in Q4 2025, up 35.06% YoY from $36.4 million in Q4 2024, and up 14.82% on a QoQ basis from $42.8 million in Q3 2025.
Celcuity (CELC) Operating Expenses (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Operating Expenses data on file, last reported at $49.2 million in Q4 2025.
- Quarterly Operating Expenses rose 35.06% year-over-year to $49.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $172.2 million (up 52.02% YoY) and the FY2025 annual result came in at $172.2 million, up 52.02% from the prior year.
- Operating Expenses grew to $49.2 million in Q4 2025, from $42.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $49.2 million in Q4 2025 to a low of $2.8 million in Q1 2021.
- A 5-year average of $21.0 million and a median of $17.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses surged 516.25% — and 2022, when it fell 29.63%.
- Tracing CELC's Operating Expenses over 5 years: stood at $6.3 million in 2021, then surged by 84.14% to $11.6 million in 2022, then soared by 69.51% to $19.7 million in 2023, then jumped by 84.65% to $36.4 million in 2024, then jumped by 35.06% to $49.2 million in 2025.
- The last three Operating Expenses figures came in at $49.2 million (Q4 2025), $42.8 million (Q3 2025), and $44.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 66.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.12 Mn |
| Dec 31, 2025 | 49.20 Mn |
| Sep 30, 2025 | 42.85 Mn |
| Jun 30, 2025 | 44.01 Mn |
| Mar 31, 2025 | 36.13 Mn |
| Dec 31, 2024 | 36.43 Mn |
| Sep 30, 2024 | 30.06 Mn |
| Jun 30, 2024 | 24.28 Mn |
| Mar 31, 2024 | 22.49 Mn |
| Dec 31, 2023 | 19.73 Mn |
| Sep 30, 2023 | 18.90 Mn |
| Jun 30, 2023 | 15.06 Mn |
| Mar 31, 2023 | 12.55 Mn |
| Dec 31, 2022 | 11.64 Mn |
| Sep 30, 2022 | 10.64 Mn |
| Jun 30, 2022 | 9.60 Mn |
| Mar 31, 2022 | 7.51 Mn |
| Dec 31, 2021 | 6.32 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 13.64 Mn |